Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Sativex – Investigational Cannabis-Based treatment for Pain and Multiple Sclerosis

Drug (brand / generic)

Sativex

Company / licensee

GW Phamaceuticals / Bayer / Otsuka / Amirall

Therapy class

Cannabis extract containing THC and CBD

Product description

Whole plant medicinal cannabis extract

Current indication

Pain and symptom relief in MS and neuropathic-related cancer pain

Market sector

CNS - pain

Development status

Approved Canada, the UK and Spain
Expand

Go Top